References
Bouchard C,
Daw EW,
Rice T et al.
(1998)
Familial resemblance for VO2max in the sedentary state: the HERITAGE family study.
Medicine and Science in Sports and Exercise
30:
252–258.
Bouchard C,
Lesage R,
Lortie G et al.
(1986)
Aerobic performance in brothers, dizygotic and monozygotic twins.
Medicine and Science in Sports and Exercise
18:
639–646.
Bouchard C,
Malina RM and
Perusse L
(1997)
Genetics of Fitness and Physical Performance.
Chaign, IL: Human Kinetics Publishers.
Bouchard C,
Rankinen T,
Chagnon YC et al.
(2000)
Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE family study.
Journal of Applied Physiology
88:
551–559.
Bray MS,
Hagberg JM,
Perusse L et al.
(2009)
The human gene map for performance and health‐related fitness phenotypes: the 2006‐2007 update.
Medicine and Science in Sports and Exercise
41:
35–73.
de la Chapelle A,
Traskelin AL and
Juvonen E
(1993)
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.
Proceedings of the National Academy of Sciences of the USA
90:
4495–4499.
Druzhevskaya AM,
Ahmetov II,
Astratenkova IV et al.
(2008)
Association of the ACTN3 R577X polymorphism with power athlete status in Russians.
European Journal of Applied Physiology
103:
631–634.
Eynon N,
Alves AJ,
Meckel Y et al.
(2010)
Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance?
Metabolism
[Epub ahead of print, PMID: 20028934].
Franklin BA,
Fletcher GF,
Gordon NF et al.
(1997)
Cardiovascular evaluation of the athlete. Issues regarding performance, screening and sudden cardiac death.
Sports Medicine
24:
97–119.
Gayagay G,
Yu B,
Hambly B et al.
(1998)
Elite endurance athletes and the ACE I allele: the role of genes in athletic performance.
Human Genetics
103:
48–50.
Hamel P,
Simoneau JA,
Lortie G et al.
(1986)
Heredity and muscle adaptation to endurance training.
Medicine and Science in Sports and Exercise
18:
690–696.
Henderson J,
Withford‐Cave JM,
Duffy DL et al.
(2005)
The EPAS1 gene influences the aerobic‐anaerobic contribution in elite endurance athletes.
Human Genetics
118:
416–423.
Katzmarzk P and
Bouchard C
(2005)
Human Body Composition,
2nd edn.
Champaign, IL: Human Kinetics Publishers.
Klissouras V
(1971)
Heritability of adaptive variation.
Journal of Applied Physiology
31:
338–344.
Klissouras V
(1973)
Prediction of potential performance with special reference to heredity.
Journal of Sports Medicine and Physical Fitness
13:
100–107.
Klissouras V and
Pigozzi F
(2009)
Genetic limits of sport performance: Quo vadis?
Journal of Sports Medicine and Physical Fitness
49:
1–5.
Komi PV,
Klissouras V and
Karvinen E
(1973)
Genetic variation in neuromuscular performance.
Internationale Zeitschrift fur angewandte Physiologie, einschliesslich Arbeitshpysiologie
31:
289–304.
MacArthur DG,
Seto JT,
Chan S et al.
(2008)
An Actn3 knockout mouse provides mechanistic insights into the association between alpha‐actinin‐3 deficiency and human athletic performance.
Human Molecular Genetics
17:
1076–1086.
Maes HH,
Beunen GP,
Vlietinck RF et al.
(1996)
Inheritance of physical fitness in 10‐yr‐old twins and their parents.
Medicine and Science in Sports and Exercise
28:
1479–1491.
Malina RM and
Bouchard C
(1986)
Sport and Human Genetics.
Champaign, IL: Human Kinetics Publishers.
Mokone GG,
Schwellnus MP,
Noakes TD et al.
(2006)
The COL5A1 gene and Achilles tendon pathology.
Scandinavian Journal of Medicine and Science in Sports
16:
19–26.
Montgomery HE,
Marshall R,
Hemingway H et al.
(1998)
Human gene for physical performance.
Nature
393:
221–222.
Niemi AK and
Majamaa K
(2005)
Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes.
European Journal of Human Genetics
13:
965–969.
Oie E,
Ahmed MS,
Ueland T et al.
(2010)
Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure.
Basic Research in Cardiology
105:
89–98.
Papadimitriou ID,
Papadopoulos C,
Kouvatsi A et al.
(2008)
The ACTN3 gene in elite Greek track and field athletes.
International Journal of Sports Medicine
29:
352–355.
Prud'homme D,
Bouchard C,
Leblanc C et al.
(1984)
Sensitivity of maximal aerobic power to training is genotype‐dependent.
Medicine and Science in Sports and Exercise
16:
489–493.
Roth SM,
Walsh S,
Liu D et al.
(2008)
The ACTN3 R577X nonsense allele is under‐represented in elite‐level strength athletes.
European Journal of Human Genetics
16:
391–394.
Santiago C,
Gonzalez‐Freire M,
Serratosa L et al.
(2008)
ACTN3 genotype in professional soccer players.
British Journal of Sports Medicine
42:
71–73.
Sebat J
(2007)
Major changes in our DNA lead to major changes in our thinking.
Nature Genetics
39:
S3–S5.
Simoneau JA,
Lortie G,
Boulay MR et al.
(1986)
Inheritance of human skeletal muscle and anaerobic capacity adaptation to high‐intensity intermittent training.
International Journal of Sports Medicine
7:
167–171.
Woods D
(2009)
Angiotensin‐converting enzyme, renin‐angiotensin system and human performance.
In: Collins M (ed.)
Genetics and Sports,
pp. 72–87.
Basel: Karger.
Yanagawa B and
Nagaya N
(2007)
Adrenomedullin: molecular mechanisms and its role in cardiac disease.
Amino Acids
32:
157–164.
Yang N,
MacArthur DG,
Gulbin JP et al.
(2003)
ACTN3 genotype is associated with human elite athletic performance.
American Journal of Human Genetics
73:
627–631.
Yu B
(2008)
In silico gene discovery.
In: Trent RJ (ed.)
Clinical Bioinformatics,
pp. 1–22.
Totowa, NJ: Humana Press.
Further Reading
Collins M (ed.)
(2009)
Genetics and Sports. Medicine and Sport Science,
pp. 1–195.
Basel: Karger.
Ostrander ER,
Huson HJ and
Ostrander GK
(2009)
Genetics of athletic performance.
Annual Review of Genomics and Human Genetics
10:
407–429.